Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
This study has been completed.
Sigma Tau Pharmaceuticals, Inc.
Information provided by:
FDA Office of Orphan Products Development
First received: February 2, 2001
Last updated: June 23, 2005
Last verified: April 2001
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||February 2001|
|Estimated Primary Completion Date:||No date given|